{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-25-013380","form_type":"8-K","ticker":"RPRX","cik":"0001802768","company_name":"Royalty Pharma plc","filed_at":"2025-04-11T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.776700+00:00","generated_at":"2026-05-23T16:17:28.677097+00:00","sec_items":["1.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Royalty Pharma amends purchase agreement to issue Class B shares to sellers at closing","bullets":["Amendment No. 1 adds Royalty Pharma plc as a party to the existing Purchase Agreement.","At closing, each seller will subscribe for Class B ordinary shares equal to the Class E shares of RPH received.","Subscription price is nominal $0.000001 per share, paid in cash by sellers to the company.","Amendment facilitates the transaction to acquire all equity interests of RP LLC, disclosed in January 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-25-013380","json":"https://secwatch.observer/filing/0001140361-25-013380.json","markdown":"https://secwatch.observer/filing/0001140361-25-013380.md","text":"https://secwatch.observer/filing/0001140361-25-013380.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1802768/000114036125013380/0001140361-25-013380-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1802768/000114036125013380/ef20047282_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T16:17:28.677097+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}